187 related articles for article (PubMed ID: 35681633)
1. Bottom-Up Approach to the Discovery of Clinically Relevant Biomarker Genes: The Case of Colorectal Cancer.
Kamel F; Schneider N; Nisar P; Soloviev M
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681633
[TBL] [Abstract][Full Text] [Related]
2. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
Rademakers G; Massen M; Koch A; Draht MX; Buekers N; Wouters KAD; Vaes N; De Meyer T; Carvalho B; Meijer GA; Herman JG; Smits KM; van Engeland M; Melotte V
Clin Epigenetics; 2021 Apr; 13(1):80. PubMed ID: 33858496
[TBL] [Abstract][Full Text] [Related]
3. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
[TBL] [Abstract][Full Text] [Related]
4. Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer.
Hauptman N; Jevšinek Skok D; Spasovska E; Boštjančič E; Glavač D
BMC Med Genomics; 2019 Apr; 12(1):54. PubMed ID: 30987631
[TBL] [Abstract][Full Text] [Related]
5. ToP: a trend-of-disease-progression procedure works well for identifying cancer genes from multi-state cohort gene expression data for human colorectal cancer.
Chung FH; Lee HH; Lee HC
PLoS One; 2013; 8(6):e65683. PubMed ID: 23799036
[TBL] [Abstract][Full Text] [Related]
6. Colorectal Cancer Diagnosis: The Obstacles We Face in Determining a Non-Invasive Test and Current Advances in Biomarker Detection.
Kamel F; Eltarhoni K; Nisar P; Soloviev M
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454792
[TBL] [Abstract][Full Text] [Related]
7. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
Heiss JA; Brenner H
Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
[TBL] [Abstract][Full Text] [Related]
8. Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation.
Qian J; Tikk K; Werner S; Balavarca Y; Saadati M; Hechtner M; Brenner H
J Clin Epidemiol; 2018 Dec; 104():24-34. PubMed ID: 30076979
[TBL] [Abstract][Full Text] [Related]
9. A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat.
Xu R; Wang Q; Li L
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S4. PubMed ID: 26100814
[TBL] [Abstract][Full Text] [Related]
10. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer.
Chen H; Qian J; Werner S; Cuk K; Knebel P; Brenner H
Clin Epidemiol; 2017; 9():517-526. PubMed ID: 29184444
[TBL] [Abstract][Full Text] [Related]
12. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S
Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
[TBL] [Abstract][Full Text] [Related]
13. TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
Jing L; Feng L; Zhou Z; Shi S; Deng R; Wang Z; Zhang Y; Ren Z; Liu Y
Oncol Rep; 2020 Aug; 44(2):628-636. PubMed ID: 32627044
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis.
Chen D; Sun Q; Cheng X; Zhang L; Song W; Zhou D; Lin J; Wang W
Cancer Med; 2016 Jul; 5(7):1629-39. PubMed ID: 27165481
[TBL] [Abstract][Full Text] [Related]
16. Screening for Colorectal Cancer Leading into a New Decade: The "Roaring '20s" for Epigenetic Biomarkers?
Almeida-Lousada H; Mestre A; Ramalhete S; Price AJ; de Mello RA; Marreiros AD; Neves RPD; Castelo-Branco P
Curr Oncol; 2021 Nov; 28(6):4874-4893. PubMed ID: 34898591
[TBL] [Abstract][Full Text] [Related]
17. Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.
Zhang J; Yan B; Späth SS; Qun H; Cornelius S; Guan D; Shao J; Hagiwara K; Van Waes C; Chen Z; Su X; Bi Y
Cell Biosci; 2015; 5():53. PubMed ID: 26388988
[TBL] [Abstract][Full Text] [Related]
18. Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review.
Raut JR; Guan Z; Schrotz-King P; Brenner H
Clin Epigenetics; 2020 Aug; 12(1):122. PubMed ID: 32778176
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
[TBL] [Abstract][Full Text] [Related]
20. Cell-surface markers for colon adenoma and adenocarcinoma.
Sewda K; Coppola D; Enkemann S; Yue B; Kim J; Lopez AS; Wojtkowiak JW; Stark VE; Morse B; Shibata D; Vignesh S; Morse DL
Oncotarget; 2016 Apr; 7(14):17773-89. PubMed ID: 26894861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
